“Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study”, Dermatol Pract Concept, vol. 14, no. 4, p. e2024250, Oct. 2024, doi: 10.5826/dpc.1404a250.